Hotpennystocknews.com is devoted to fetch you the most exclusive stocks in the market today. Apart from scanning the markets for the most underrated stocks. We propel those victors directly to your email inbox first ahead of the rest of the marketplace gets a prospect.
Los Angeles, CA -- (SBWIRE) -- 01/24/2014 -- Hotpennystocknews.com issues special report on - Fresh Healthy Vending International Inc (VEND),Kallo Inc (OTCMKTS:KALO),BNCCORP, Inc. (OTCMKTS:BNCC),Oncosec Medical Incorporated (OTCMKTS:ONCS)
Fresh Healthy Vending International Inc (VEND) is a healthy vending machine company. It is operator of Company-owned vending machines that make healthy eating convenient through access to high quality healthy foods at high foot traffic vending destinations.
VEND sstarted its trading session with the price of$3.22 and closed at $3.24 by scoring 2.86%. Fresh Healthy Vending International Inc stocks traded with total volume of $ 170,585.00 shares, while the average trading volume remained $ 270,625.00 shares.Day range of the stock was $3.03 - $3.24.
Will Fresh Healthy Vending International Inc Get Buyers Even After The Recent Rally? Find Out Here.
Kallo Inc (OTCMKTS:KALO) is a medical information company that uses technology to assist physicians and nurses to streamline the mass of patient information in a coherent and usable manner. Their clinical information systems are designed for use in hospitals, healthcare delivery organizations and regional and national healthcare authorities. Their corporate mission is to help healthcare professionals practice the best possible medicine, at the point of care.
Their intend to market leading-edge technology solutions for healthcare institutions and authorities. These solutions are designed to save cost, time and reduce adverse drug events (ADE) that kill more than 200,000 patients per year in the United States alone. Their latest generation suite of software modules comprises a fully functional clinical information system (Clinical Information System) that includes the complete electronic medical record (Electronic Medical Record), with a core Computerized Physician Order Entry (CPOE) module. Their Clinical Information System, Electronic Medical Record and CPOE work together to reduce the cost of providing medical care, while dramatically improving the quality and efficiency of healthcare services offered by healthcare institutions.
KALO are trading at $0.28 and is +500.00% from its 50-day Moving Average price of $0.0467 and +704.13% from its 200-day Moving Average price of $0.0348. The average trading volume is 67019 shares and its market capitalization is $86.1M.
Should Investor Buy OR Sell This Stock : CLICK HERE.
BNCCORP, Inc. (OTCMKTS:BNCC), a company that operates community banking and wealth management businesses and mortgage banking offices, Friday reported a plunge in the fourth-quarter earnings chiefly due to a decrease in mortgage banking revenues.
Earnings fell to $1.88 million, or $0.44 per share, from $4.98 million, or $1.34 per share, a year ago.Mortgage banking revenues were $1.93 million during the quarter, compared with $8.23 million in the same period last year.
Net interest income increased 29 percent to $6.01 million from $4.66 million a year ago, chiefly on account of a $101.9 million rise in average balance of interest-earning assets. Net interest margin rose to 3.07 percent from 2.75 percent last year. The company reported that the provision for loan losses remained nil for both the periods.
For the three months to December, non-interest income fell 52.3 percent to $4.61 million from $9.66 million a year ago, mainly due to decrease in mortgage banking revenues. Non-interest expenses was $8.07 million, compared with $8.97 million a year ago.
For earnings history and earnings-related data on BNCCORP, click here.
Oncosec Medical Incorporated (OTCMKTS:ONCS) develops novel ElectroOncology therapies that combine its proprietary electroporation delivery technology with a chemotherapeutic or novel DNA-based immunotherapeutics.Targeted delivery of these agents is designed to achieve selective destruction of cancerous tumors, resulting in improved functional, cosmetic and quality of life outcomes.
Keep a close eye on ONCS, as the stock has been showing unusual moves over the past weeks. At Current market price, ONCS has recovered +163.89% from its 52-week Low of 0.18 and has Pulled back -16.67% from its 52-week high of 0.57.
For More Details On ONCS, 100 % free Sign Up Here.
Neither Hotpennystocknews.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor or broker dealer in any jurisdiction whatsoever and none of the information provided by Hotpennystocknews.com, owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or an investment recommendation.Hotpennystocknews.com makes no recommendation that the securities of the companies profiled should be purchased, sold or held by individuals or entities that learn of the profiled companies through Hotpennystocknews.com. Investing in securities is speculative and carries a high degree of risk and no investment should be made unless you can afford to lose your entire investment. It is possible that an investor's entire investment may be lost or impaired due to the speculative nature of the companies profiled. Please consult a broker before purchasing or selling any securities viewed on or mentioned here in.
Read Full disclaimer at:http://www.hotpennystocknews.com/disclaimer.php
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)